Advertisement

Topics

Amgen-Aktie fehlen signifikante Katalysatoren! - Aktienanalyse

08:34 EDT 28 Jul 2017 | FinanzNachrichten

Toronto - Amgen-Aktienanalyse des Analysten M. Ian Somaiya von BMO Capital Markets: Aktienanalyst M. Ian Somaiya vom Investmenthaus BMO Capital Markets äußert laut einer Aktienanalyse nur noch die ...

Original Article: Amgen-Aktie fehlen signifikante Katalysatoren! - Aktienanalyse

NEXT ARTICLE

More From BioPortfolio on "Amgen-Aktie fehlen signifikante Katalysatoren! - Aktienanalyse"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...